|
D3 Receptor
Dopamine receptor D3 is a protein that in humans is encoded by the ''DRD3'' gene. This gene encodes the D3 subtype of the dopamine receptor. The D3 subtype inhibits adenylyl cyclase through inhibitory G-proteins. This receptor is expressed in phylogenetically older regions of the brain, suggesting that this receptor plays a role in cognitive and emotional functions. It is a target for drugs which treat schizophrenia, drug addiction, and Parkinson's disease. Alternative splicing of this gene results in multiple transcript variants that would encode different isoforms, although some variants may be subject to nonsense-mediated decay (NMD). Function Alpha-synuclein (α-Syn) aggregation via Lewy bodies inclusion, a pathogenic signature exclusively present in PD patients, is decreased by D3 agonists while DA content is elevated by inhibiting DA reuptake and breakdown. The regulation of α-Syn aggregation and clearance enhances brain-derived neurotrophic factor (BDNF) secretion, whi ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
PF-219,061
PF-219,061 is a drug that was under drug development, development by Pfizer which acts as a potent and highly functional_selectivity, selective agonist for the dopamine D3_receptor, D3 Receptor (biochemistry), receptor. It was under development as a potential medication for the treatment of female sexual dysfunction. It did not advance into clinical trials. See also * ABT-670 * ABT-724 * Cabergoline * Bremelanotide * Flibanserin * Intrinsa * Melanotan II * OSU-6162 * PF-592,379 * Pramipexole * Tibolone * UK-414,495 References {{Dopaminergics Dopamine agonists Female sexual dysfunction drugs Phenylmorpholines Phenols Pfizer brands Abandoned drugs Aphrodisiacs ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
PF-592,379
PF-592,379 is a drug developed by Pfizer which acts as a potent, selective and orally active agonist for the dopamine D3 receptor, which is under development as a potential medication for the treatment of female sexual dysfunction and male erectile dysfunction. Unlike some other less selective D3 agonists, a research study showed that PF-592,379 has little abuse potential in animal studies, and so was selected for further development and potentially human clinical trials. Development has since been discontinued. See also * 7-OH-DPAT * PD-128,907 * PF-219,061 PF-219,061 is a drug that was under drug development, development by Pfizer which acts as a potent and highly functional_selectivity, selective agonist for the dopamine D3_receptor, D3 Receptor (biochemistry), receptor. It was under development as ... References {{Dopaminergics Dopamine agonists Female sexual dysfunction drugs Morpholines Pfizer brands Abandoned drugs Aminopyridines Aphrodisiacs ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Protein
Proteins are large biomolecules and macromolecules that comprise one or more long chains of amino acid residues. Proteins perform a vast array of functions within organisms, including catalysing metabolic reactions, DNA replication, responding to stimuli, providing structure to cells and organisms, and transporting molecules from one location to another. Proteins differ from one another primarily in their sequence of amino acids, which is dictated by the nucleotide sequence of their genes, and which usually results in protein folding into a specific 3D structure that determines its activity. A linear chain of amino acid residues is called a polypeptide. A protein contains at least one long polypeptide. Short polypeptides, containing less than 20–30 residues, are rarely considered to be proteins and are commonly called peptides. The individual amino acid residues are bonded together by peptide bonds and adjacent amino acid residues. The sequence of amino acid residue ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Pergolide
Pergolide, sold under the brand name Permax and Prascend (veterinary) among others, is an ergoline-based dopamine receptor agonist used in some countries for the treatment of Parkinson's disease. Parkinson's disease is associated with reduced dopamine activity in the substantia nigra of the brain. Pergolide acts on many of the same receptors as dopamine to increase receptor activity. It was patented in 1978 and approved for medical use in 1989. In 2007, pergolide was withdrawn from the U.S. market for human use after several published studies revealed a link between the drug and increased rates of valvular heart disease. However, a veterinary form of pergolide, marketed under the trade name Prascend, is permitted for the treatment of pituitary pars intermedia dysfunction (PPID) also known as equine Cushing's syndrome (ECS) in horses. Medical uses Pergolide is not available for use by humans in the United States, however, it is still used in various other countries, where it is ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Quinelorane
Quinelorane is a drug which acts as a dopamine agonist A dopamine agonist (DA) is a compound that activates dopamine receptors. There are two families of dopamine receptors, D2-like and D1-like, and they are all G protein-coupled receptors. D1- and D5-receptors belong to the D1-like family and the ... for the D2 and D3 receptor. See also * Quinpirole References Dopamine agonists Aminopyrimidines {{nervous-system-drug-stub ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Pramipexole
Pramipexole, sold under the brand Mirapex among others, is medication used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). In Parkinson's disease it may be used alone or together with levodopa. It is taken by mouth. Pramipexole is a dopamine agonist of the non-ergoline class. Studies have shown detrimental side effects resulting from off-label use of pramipexole or other dopamine agonists in treating clinical depression. Pramipexole was approved for medical use in the United States in 1997. Use in pregnancy and breastfeeding is of unclear safety. It is available as a generic medication. In 2020, it was the 193rd most commonly prescribed medication in the United States, with more than 2million prescriptions. Medical uses Pramipexole is used in the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS). Use in pregnancy and breastfeeding is of unclear safety. It is occasionally prescribed off-label for depression. Its effectiveness as an an ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Piribedil
Piribedil (trade names Pronoran, Trivastal Retard, Trastal, Trivastan, Clarium and others) is an antiparkinsonian agent and piperazine derivative which acts as a D2 and D3 receptor agonist. It also has α2-adrenergic antagonist properties. Medical uses * Treatment of Parkinson's disease (PD), either as monotherapy (without levodopa)) or in combination with L-DOPA therapy, in the early stages of the disease as well as in the advanced ones * Treatment of pathological cognitive deficits in the elderly (impaired attention, motivation, memory, etc.) * Treatment of dizziness in the young patients * Treatment of retinal ischemic manifestations * Adjunctive treatment of intermittent claudication due to peripheral vascular disease (PVD) of the lower limbs (stage 2) * Adjunctive treatment of anhedonia and treatment-resistant depression in unipolar and bipolar depressives (''off label'') * Treatment of gait disorders associated with Parkinson's disease (no related cause) and other f ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
PD-128,907
PD-128,907 is a drug used in scientific research which acts as a potent and selective agonist for the dopamine D2 and D3 receptors. It is used for studying the role of these receptors in the brain, in roles such as inhibitory autoreceptors that act to limit further dopamine release, as well as release of other neurotransmitters. In animal studies it has been shown to reduce toxicity from cocaine overdose. See also * 7-OH-DPAT * PF-219,061 * PF-592,379 PF-592,379 is a drug developed by Pfizer which acts as a potent, selective and orally active agonist for the dopamine D3 receptor, which is under development as a potential medication for the treatment of female sexual dysfunction and male erec ... References Dopamine agonists Benzopyrans Phenols Phenylmorpholines {{nervous-system-drug-stub ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
ES609
ECMAScript (; ES) is a JavaScript standard intended to ensure the interoperability of web pages across different web browser, browsers. It is standardized by Ecma International in the documenECMA-262 ECMAScript is commonly used for client-side scripting on the World Wide Web, and it is increasingly being used for writing server-side applications and services using Node.js and other runtime environments. ECMAScript, ECMA-262 and JavaScript ECMA-262, or the ''ECMAScript Language Specification'', defines the ''ECMAScript Language'', or just ECMAScript. ECMA-262 specifies only language syntax and the semantics of the core API, such as , , and , while valid implementations of JavaScript add their own functionality such as input-output and file-system handling. History The ECMAScript specification is a standardized specification of a scripting language developed by Brendan Eich of Netscape Communications Corporation, Netscape; initially named Mocha, then LiveScript, and finally J ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
